We often think we know more than we actually do. While four in five Americans consider themselves knowledgeable about the human body, only one in ten knows that O-negative is the universal blood type, ...

This marks the first live procedure at AAHS, as well as a first for Keenova. Treatment takes place over two days of annual meeting—injection on Wednesday and finger extension on Friday. Audience of ...

Encoded Therapeutics, Inc. ("Encoded"), a clinical-stage biotechnology company developing precision genetic medicines for severe neurological disorders, today announced that the U.S. Food and Drug ...

– Designation recognizes the potential of ETX101 to address a serious condition with high unmet need – Encoded Therapeutics, Inc. (“Encoded”), a clinical-stage biotechnology company developing ...

Fatigue can stem from a variety of illnesses and life stressors, but when that exhaustion lasts for months — often following an infection — it may indicate a condition called chronic fatigue syndrome.

Note: Some submissions are from this Reddit thread. 1. "Pentalogy of Cantrell, which is when the heart is outside of the chest because the sternum has not fused. I'd seen it before with just a bit of ...

Credit: Acadia. Daybue Stix, a strawberry-flavored trofinetide powder mixable with water-based liquids, gains FDA approval for Rett syndrome treatment. Acadia expects to have the new formulation ...

Intrauterine growth restriction (IUGR), metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies (IMAGe) syndrome is a multisystem disorder. Infants affected with IMAGe syndrome are ...

In the Neurology Department at Allegheny General Hospital’s Hemlock Building, Abigail Bailey’s body folded forward in her chair. Her muscles tightened as if someone had forced the air from her lungs.

BAY 3401016 is an investigational monoclonal antibody with potential to block a protein called Semaphorin 3A (Sema3A), which is thought to be involved in the progression of kidney damage in Alport ...

Biologics, including GLP-1 analogs and PCSK9 inhibitors, are advancing treatment options for metabolic syndrome components like type 2 diabetes and dyslipidemia. GLP-1 receptor agonists improve ...